BANK OF AMERICA CORP /DE/ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$319,134
+6.6%
188,837
+75.4%
0.00%
Q2 2023$299,314
-5.8%
107,667
-38.3%
0.00%
Q1 2023$317,637
-91.9%
174,526
-77.4%
0.00%
Q4 2022$3,912,996
+168.6%
771,794
+163.1%
0.00%
Q3 2022$1,457,000
+723.2%
293,350
+516.7%
0.00%
Q2 2022$177,000
-43.6%
47,569
-14.9%
0.00%
Q1 2022$314,000
-68.2%
55,897
-65.5%
0.00%
Q4 2021$987,000
+26.5%
162,188
+102.4%
0.00%
Q3 2021$780,000
-3.0%
80,135
+42.4%
0.00%
Q2 2021$804,000
-6.5%
56,290
+55.4%
0.00%
Q1 2021$860,00036,2120.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders